ImmunoGen, Inc.

ImmunoGen is now part of AbbVie. Together, we’ll work to advance innovation in #ADCs and help transform standards of care for people living with #cancer - offering them more good days. Follow AbbVie for all future updates and learn more: https://bit.ly/3OF7Tdq

Last week we held our first All Company Meeting of 2024! #TeamImmunoGen came together to hear updates from our CEO, Mark Enyedy, sit in on a fireside chat led by Michael Method with an #ovariancaner survivor named Susanna, and gain insight from our COO, Isabel Kalofonos, on our commercial activities. We're ready and excited for all of the growth and expansion ahead in 2024 – and beyond. #TargetABetterNow #MoreGoodDays 

Cervical cancer can be detected with a Pap test. Breast cancer can be detected with mammograms and clinical breast exams. #Ovariancancer, however, does not have a routine screening exam to detect it in its earliest stages. This is a truth that Jess came to know, heartbreakingly, at just 27 years old. After wading through second and third opinions, debulking surgeries, and 18 weeks of traditional treatments, Jess came out the other side with an urgency to experience this world – and this life - from its highest heights. We invite you to watch Jess’ story, called The Climb: https://lnkd.in/gc22_CWm.

This Sunday marks #WorldCancerDay – a moment for us to reflect on the impact of #cancer and how we can help educate on early detection and prevention, and provide support for those affected. #TeamImmunoGen understands cancer disrupts lives, which is why we believe in working together to help #CloseTheCareGap to remove health inequities, and enable access to vital healthcare services that everyone deserves. Learn how you can get involved and help create change in #cancer care by visiting: https://lnkd.in/enRpVVtf.

Meet our Finance team! This group serves as strategic financial partners across all aspects of our business, from financial planning and analysis to accounting and reporting. They set #TeamImmunoGen up for success and ensure the overall financial health of our organization so we can continue to innovate and deliver #moregoodays for #patients with #cancer. We are grateful to have them on board!

Welcome the newest members of #TeamImmunoGen! We are pleased to have this group of talented individuals on board as we continue to work to bring #moregooddays to #patients with #cancer. 

Meet Anna (Missy) Richard, who has been with #TeamImmunoGen for nearly 30 years as an Executive Assistant! Her responsibilities include supporting our Regulatory Affairs, Technical Operations, and Quality teams by managing schedules and handling tasks to ensure a smooth workflow for all. We value Missy’s expertise as we work to deliver targeted therapies to #patients living with #cancer.

As we wrap up 2023, we’d like to thank each member of #TeamImmunoGen for their contributions to bringing the business to where it is today, while working relentlessly to offer #patients with #cancer #moregooddays. The last 12 months have been remarkable and a testament to our collective superlative performance. We look forward in continuing to deliver on the business in 2024! #TargetABetterNow #WithCareWeCanAndWeWill

Meet our Commercial Strategy and Operations team! Responsible for all things brand planning, launch readiness, marketing operations, field force effectiveness, and insights and analytics, we are thankful for Anne Bitner, Alok Joshi, Steve Stark, Elizabeth Oubre, and Alexandra Makarova, MD, PhD. We appreciate their hard work and contributions in bringing #moregooddays to #patients with #cancer. #TeamImmunoGen

#TeamImmunoGen gathered in Boston’s Seaport at the Tuscan Kitchen for our annual holiday party filled with fun, food, laughter, and dancing. Together with our friends and family, we had blast and are thankful to have had the opportunity to celebrate an amazing 2023 - in style!